There have been some medications for prostate cancer approved more recently that are having an enormous impact on men whose disease has spread. Abiraterone, for one (trade name Zytiga and also Yonsa, which was recently FDA-approved ), blocks the enzyme that makes testosterone and has boosted survival rates in late-stage prostate cancer patients when combined with androgen deprivation therapy.
Dr. Stephen Freedland, a urologist at Cedars-Sinai Medical Center, says studies have shown that men “
Read More